CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 71.95 M

CSPC Innovation Pharmaceutical Co., Ltd. Current Liabilities is USD 71.95 M for the year ending December 31, 2023, a -14.80% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

CSPC Innovation Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 84.45 M, a 132.25% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 36.36 M, a 1.32% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 35.89 M, a -37.64% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 57.55 M, a 13.30% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years